• IPXIII will take place in September 2021 - Venue to confirmed soon


Dr Sabina Halappanavar

Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada


Dr. Sabina Halappanavar is a Research Scientist in the Mechanistic Studies Division of Environmental Health Science and Research Bureau of Health Canada and an Adjunct Professor at the Department of Biology, University of Ottawa. Her research activities involve evaluation of usefulness of systems biology approaches in hazard identification, risk calculation and supporting regulatory decision-making for human health risk assessment related to environmental chemicals but primarily related to nanomaterials. The specific focus of her ongoing research is to investigate the molecular mechanisms of particle-induced pulmonary toxicity and lung diseases using in vivo, in vitro and ex vivo models. Dr. Halappanavar’s research was recognised by Health Canada in 2016 with the Assistant Deputy Minister and Deputy Minister’s Excellence in Science awards. Dr. Halappanavar serves on international Science Advisory Board of the European Union Research 7th Framework Program Projects and  EU H2020 consortia. She is also a temporary advisor to WHO on the development of Environmental Health Criteria Document on Principles and Methods to Assess the Risk of Immunotoxicity Associated with Exposure to Nanomaterials. She is contributing to OECD’s Adverse Outcome Pathway (AOP) initiative by developing AOPs for pulmonary diseases induced by nanomaterials. She provides inputs to regulatory and policy approaches discussed for nanotoxicology at the branch/departmental level at Health Canada. She leads several international collaborations and has served as Canadian expert on CAC-ISO-TC229 nanotechologies forum. Dr. Halappanavar obtained a M.Sc in Experimental Medicine and a Ph.D. in Molecular and Cellular Biology at Université Laval, Quebec.